EARNEST Partners’s AbbVie ABBV Stock Holding History

EARNEST Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+872	New	+$188K	﹤0.01%	299
2025 Q4	–	Sell	-908	Closed	-$210K	–	300
2025 Q3	$210K	Buy	+908	New	+$185K	﹤0.01%	286
2023 Q4	–	Sell	-847	Closed	-$126K	–	291
2023 Q3	$126K	Hold	847	–	–	﹤0.01%	310
2023 Q2	$114K	Hold	847	–	–	﹤0.01%	298
2023 Q1	$135K	Hold	847	–	–	﹤0.01%	287
2022 Q4	$137K	Hold	847	–	–	﹤0.01%	288
2022 Q3	$114K	Hold	847	–	–	﹤0.01%	282
2022 Q2	$130K	Hold	847	–	–	﹤0.01%	276
2022 Q1	$137K	Hold	847	–	–	﹤0.01%	273
2021 Q4	$115K	Hold	847	–	–	﹤0.01%	284
2021 Q3	$91K	Hold	847	–	–	﹤0.01%	289
2021 Q2	$95K	Hold	847	–	–	﹤0.01%	285
2021 Q1	$92K	Hold	847	–	–	﹤0.01%	280
2020 Q4	$91K	Hold	847	–	–	﹤0.01%	278
2020 Q3	$74K	Hold	847	–	–	﹤0.01%	279
2020 Q2	$83K	Buy	847 +139	+20%	+$12.2K	﹤0.01%	267
2020 Q1	$54K	Hold	708	–	–	﹤0.01%	291
2019 Q4	$63K	Hold	708	–	–	﹤0.01%	297
2019 Q3	$54K	Hold	708	–	–	﹤0.01%	305
2019 Q2	$51K	Hold	708	–	–	﹤0.01%	311
2019 Q1	$57K	Hold	708	–	–	﹤0.01%	299
2018 Q4	$65K	Sell	708 -60	-8%	-$5.28K	﹤0.01%	277
2018 Q3	$73K	Hold	768	–	–	﹤0.01%	280
2018 Q2	$71K	Hold	768	–	–	﹤0.01%	279
2018 Q1	$73K	Hold	768	–	–	﹤0.01%	278
2017 Q4	$74K	Buy	+768	New	+$72.4K	﹤0.01%	270
2017 Q1	–	Sell	-768	Closed	-$48K	–	231
2016 Q4	$48K	Buy	+768	New	+$46.9K	﹤0.01%	285

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EARNEST Partners's ABBV Position: Q2 2026 in Review

EARNEST Partners opened a new position in AbbVie (ABBV) in Q2 2026: 872 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #299 among its holdings. This is a return to the name: EARNEST Partners previously reported a position in ABBV as recently as Q3 2025.

EARNEST Partners first reported a position in ABBV in Q4 2016 and has held it in 27 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

EARNEST Partners held 872 shares of AbbVie worth $219K as of Q2 2026.
AbbVie was a new EARNEST Partners position in Q2 2026.
AbbVie made up ﹤0.01% of EARNEST Partners's portfolio in Q2 2026, its #299 holding.
EARNEST Partners first reported a position in AbbVie in Q4 2016 and has held it in 27 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.